Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ yfnqu4Cn
_}EGk4E
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© `BmAu[(e&
O+@"l$;N
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© Gyw@+(l
SVpvx`&kT
1.Co-stimulators (or co-stimulating molecules) Y<#WC#3=
nMNAn}~*M
2.NK-kB !r,ZyJU
7,d^?.~S
3.Immunoglobulin superfamily ]m{;yOQdsC
.1XZ9M
4.antigen-presenting cell (APC) 4~53%=+
DzkE*vR
5.death domain Vrf2%$g
KM*sLC#
6.CCR and CXCR A=o
p R
wciYv,
7.Lectin (or mitogen) U
SXz
?C(Z\"IX
8.Clusters of differentiation, CD) dJ"3F(X
l!lt
gj
9.B7 family !bFa\6]q
pM9Hav@iWU
10.Cytotoxic T lymphocyte, CTL)
w1F7gd
NIrK+uC.d
11.IL-15 and IL-15 receptor (IL-15R) !T@>Ld:
MeW8aLr
12.MHC restriction Sdz!J 1
*YZ'Uy?
13.Affinity-chromatography ez%RWck
BP6;dF5E
14.Cyctosprin A, CsA #.?DsK_:@
Zk$AAjC&
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) M6vW}APH[n
g-U'{I5F
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© pOS:/~I3
t(VG#}
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 zh2$U
dZ|M
3M
8P%
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ Y=sRVypJ
Na=9ju
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ I>k3X~cG
SE)_5|k*
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© .q
i$X!0
DKm`
ÃâÒßѧרҵ£º s@OCj0'l
aj51%wKMb:
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 9G` 2t~%
p<?~~7V
Ïû»¯ÄÚ¿Æ£º YYr &Jcj
n9]^v-]K
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ :k6|-A2
gF^l`1f"
ѪҺ²¡Ñ§×¨Òµ£º ~mOGNf?f
gZuk(
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿